Package 83831-121-04

Brand: frindovyx

Generic: cyclophosphamide
NDC Package

Package Facts

Identity

Package NDC 83831-121-04
Digits Only 8383112104
Product NDC 83831-121
Description

1 VIAL, MULTI-DOSE in 1 CARTON (83831-121-04) / 4 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 2025-03-19
Brand frindovyx
Generic cyclophosphamide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "8a1dd776-1219-455e-a47f-bc6fc921c15c", "openfda": {"upc": ["0383831119012", "0383831120025"], "unii": ["8N3DW7272P"], "rxcui": ["2703027", "2703032"], "spl_set_id": ["5ad8ea65-4c98-487a-9c8d-df778765ec5e"], "manufacturer_name": ["Avyxa Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (83831-121-04)  / 4 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "83831-121-04", "marketing_start_date": "20250319"}], "brand_name": "Frindovyx", "product_id": "83831-121_8a1dd776-1219-455e-a47f-bc6fc921c15c", "dosage_form": "INJECTION", "product_ndc": "83831-121", "generic_name": "Cyclophosphamide", "labeler_name": "Avyxa Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Frindovyx", "active_ingredients": [{"name": "CYCLOPHOSPHAMIDE", "strength": "2 g/4mL"}], "application_number": "NDA210852", "marketing_category": "NDA", "marketing_start_date": "20250319", "listing_expiration_date": "20261231"}